Inhibition of Cardiac Hypertrophy Effects in D-Galactose-Induced Senescent Hearts byAlpinate Oxyphyllae FructusTreatment
Autor: | Yung Ming Chang, Chih Yang Huang, Ray Jade Chen, Shu Luan Lin, Hen-Hong Chang, Hsin Nung Chang, Vijaya Padmaviswanadha, Chin Chuan Tsai, Hung-Jen Lin, Chuan Te Tsai |
---|---|
Rok vydání: | 2017 |
Předmět: |
0301 basic medicine
medicine.medical_specialty Article Subject business.industry lcsh:Other systems of medicine 030204 cardiovascular system & hematology lcsh:RZ201-999 medicine.disease Pathophysiology Muscle hypertrophy 03 medical and health sciences 030104 developmental biology 0302 clinical medicine Endocrinology Complementary and alternative medicine Downregulation and upregulation Ventricular hypertrophy Oral administration Internal medicine Medicine Eccentric MYH7 business Pathological Research Article |
Zdroj: | Evidence-Based Complementary and Alternative Medicine, Vol 2017 (2017) Evidence-based Complementary and Alternative Medicine : eCAM |
ISSN: | 1741-4288 1741-427X |
DOI: | 10.1155/2017/2624384 |
Popis: | Aging is a complex physiological phenomenon accelerated by ROS accumulation, with multisystem decline and increasing vulnerability to degenerative diseases and death. Cardiac hypertrophy is a key pathophysiological component that accompanies the aging process. Alpinate Oxyphyllae Fructus (Alpinia oxyphyllaMIQ, AOF) is a traditional Chinese medicine, which provides cardioprotective activity against aging, hypertension, and cerebrovascular disorders. In this study, we found the protective effect of AOF against cardiac hypertrophy in D-galactose-induced aging rat model. The results showed that treating rats with D-galactose resulted in pathological hypertrophy as evident from the morphology change, increased left ventricular weight/whole heart weight, and expression of hypertrophy-related markers (MYH7 and BNP). Both concentric and eccentric cardiac hypertrophy signaling proteins were upregulated in aging rat model. However, these pathological changes were significantly improved in AOF treated group (AM and AH) in a dose-dependent manner. AOF negatively modulated D-galactose-induced cardiac hypertrophy signaling mechanism to attenuate ventricular hypertrophy. These enhanced cardioprotective activities following oral administration of AOF reflect the potential use of AOF for antiaging treatments. |
Databáze: | OpenAIRE |
Externí odkaz: |